Aminocaproic and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Aminocaproic (aminocaproic acid), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Trasylol, and have Idiopathic thrombocytopenic purpura.

The study is created by eHealthMe based on reports of 735 people who have side effects when taking Aminocaproic from the FDA, and is updated regularly.

What is Aminocaproic?

Aminocaproic has active ingredients of aminocaproic acid. eHealthMe is studying from 737 Aminocaproic users. Check the latest studies of Aminocaproic.

On Jul, 12, 2026

735 people reported to have side effects when taking Aminocaproic.
Among them, 49 people (6.67%) died.

Among these 49 people:

How long have people been on Aminocaproic when they died? *

What is the gender of people who died when taking Aminocaproic? *

female: 47.62 %
male: 52.38 %

What is the age of people who died when taking Aminocaproic? *

What are other drugs people take besides Aminocaproic? *

Trasylol: 13 people, 26.53%
Protamine Sulfate: 11 people, 22.45%
Heparin: 9 people, 18.37%
Prednisone: 7 people, 14.29%
Vancomycin: 7 people, 14.29%
Acetaminophen: 6 people, 12.24%
Amicar: 5 people, 10.20%
Furosemide: 5 people, 10.20%
Esomeprazole Magnesium: 5 people, 10.20%
Cefazolin: 4 people, 8.16%

What are other side effects people have before they died? *

Acute Kidney Failure: 14 people, 28.57%
Injury: 13 people, 26.53%
Pain: 13 people, 26.53%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 12 people, 24.49%
Stress And Anxiety: 12 people, 24.49%
Fear: 12 people, 24.49%
Renal Injury (kidney injury): 10 people, 20.41%
Renal Impairment (severely reduced kidney function): 10 people, 20.41%
Emotional Distress: 8 people, 16.33%
Depression: 6 people, 12.24%

What are the existing conditions these people have? *

Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 8.16%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 6.12%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 6.12%
Prostate Cancer: 2 people, 4.08%
Thrombocytopenia (decrease of platelets in blood): 2 people, 4.08%
High Blood Pressure: 2 people, 4.08%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.08%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 4.08%
Anaemia (lack of blood): 2 people, 4.08%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 2.04%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aminocaproic:

Aminocaproic (737 reports)

Expand to all the drugs that have ingredients of aminocaproic acid:

Death and drugs with ingredients of aminocaproic acid (226 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aminocaproic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,132 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Aminocaproic) and Aminocaproic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.